Started in 1996, Biotecnol operated as a consultancy company, providing consultancy services to Portuguese pharmaceutical companies, and also European biotech companies. In 2000, Biotecnol attracted its first investment and was able to begin independent activities. This allowed Biotecnol to develop into the first pharmaceutical biotech research & development-driven company in Portugal. In 2002, Biotecnol accomplished further financing, which allowed Biotecnol to transition to product development. The company's early administrative quarters were located in the TagusPark science park in Oeiras near Lisbon, Portugal, and the research and development facilities were located nearby. The company was funded through a mixture of private funding (72%) and Portuguese venture capital (28%). The company is headquartered in the United Kingdom and has its Research and Development laboratories in Oeiras Portugal.